Back
Enlivex Therapeutics Quote, Financials, Valuation and Earnings
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
ENLV
Enlivex Therapeutics
Last Price:
1.19
Seasonality Move:
14.26%
7 Day Trial
ALL ACCESS PASS
$
7
The 7 new tech giants dominating today's markets
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.Enlivex Therapeutics Price Quote
$1.19
+0.01 (+0.85%)
(Updated: December 18, 2024 at 5:55 PM ET)
Enlivex Therapeutics Key Stats
Sell
37
Enlivex Therapeutics (ENLV)
is a Sell
Day range:
$1.13 - $1.24
52-week range:
$0.81 - $4.59
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.98%
Volume:
211.2K
Avg. volume:
354.9K
1-year change:
-16.31%
Market cap:
$25.9M
Revenue:
$0
EPS:
$-0.98
How Much Does Enlivex Therapeutics Make?
Data Unavailable
Is Enlivex Therapeutics Growing As A Company?
Data Unavailable
Enlivex Therapeutics Stock Price Performance
-
Did Enlivex Therapeutics Stock Go Up Last Month?
Enlivex Therapeutics share price went up by 10.28% last month -
Did ENLV's Share Price Rise Over The Last Year?
ENLV share price fell by -16.31% over the past 1 year
What Is Enlivex Therapeutics 52-Week High & Low?
-
What Is Enlivex Therapeutics’s 52-Week High Share Price?
Enlivex Therapeutics has traded as high as $4.59 over the past 52 weeks -
What Is Enlivex Therapeutics’s 52-Week Low Share Price?
Enlivex Therapeutics has traded as low as $0.81 over the past 52 weeks
Enlivex Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Enlivex Therapeutics?
-
How Much Debt Does Enlivex Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Enlivex Therapeutics Have?
Cash and short term investments quarterly total is $24.5M -
What Is Enlivex Therapeutics’s Book Value Per Share?
Book value per share is 1.21
Is Enlivex Therapeutics Cash Flow Positive?
-
What Is ENLV Cash Flow From Operations?
Cash flow from operations (TTM) is -$14.2M -
What Is Enlivex Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $5.2M -
What Is Enlivex Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $9.8M
Enlivex Therapeutics Return On Invested Capital
Data Unavailable
Enlivex Therapeutics Earnings Date & Stock Price
-
What Is Enlivex Therapeutics's Stock Price Today?
A single share of ENLV can be purchased today for 1.18 -
What Is Enlivex Therapeutics’s Stock Symbol?
Enlivex Therapeutics trades on the nasdaq under the ticker symbol: ENLV -
When Is Enlivex Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Enlivex Therapeutics is scheduled on December 20, 2024 -
When Is ENLV's next ex-dividend date?
Enlivex Therapeutics's next ex-dividend date is December 19, 2024 -
How To Buy Enlivex Therapeutics Stock?
You can buy Enlivex Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Enlivex Therapeutics Competitors
-
Who Are Enlivex Therapeutics's Competitors?
Below is a list of companies who compete with Enlivex Therapeutics or are related in some way:
Enlivex Therapeutics Dividend Yield
-
What Is ENLV Dividend Yield?
Enlivex Therapeutics’s dividend yield currently is 0% -
What Is Enlivex Therapeutics’s Payout Ratio?
Enlivex Therapeutics’s payout ratio is 0% -
When Did Enlivex Therapeutics Last Pay A Dividend?
The latest dividend pay date is December 19, 2024 -
What Is Enlivex Therapeutics’s Dividend Per Share?
Enlivex Therapeutics pays a dividend of $0.00 per share
Enlivex Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 25% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 9.50 |
| Upside from Last Price: | 705.08% |